Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treating the Partners of Drug Using Pregnant Women: Stage II (HOPE)

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Hendree E. Jones, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT00496990
First received: July 5, 2007
Last updated: March 1, 2013
Last verified: March 2013